Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2015 | 18 | 2 |
Tytuł artykułu

Epidemiological and morphological analysis of feline injection site sarcomas

Treść / Zawartość
Warianty tytułu
Języki publikacji
Feline injection site sarcomas (FISS) are malignant neoplasms of mesenchymal origin which arise in sites of injections in cats. The prevalence is estimated between 1 in 1000 and 1 in 10 000 vaccinations in the United Kingdom. The aim of this study was to estimate the incidence of FISS in Poland and to analyse clinical aspects and histological and cytological features of injection site sarcomas. In our study the prevalence of FISS was 0.16% (16 FISS on 10.000 of cats) in feline patients in one of a veterinary surgery which conducts the general practice and 85 on 10.000 cats in a practice focused on veterinary oncology. The most typical microscopic features of FISS found in the present analysis were: the presence of perilesional scarring and inflammation, aggregates of lymphocytes at the tumour periphery, moderate but usually marked cellular pleomorphism and intralesional necrosis. The most typical cytologic features of FISS found in present study were: the presence of neutrophils, marked cellular pleomorphism, the presence of lymphocytes and macrophages, the presence of extremely large nuclei in the neoplastic cells, and high sample cellularity.
Słowa kluczowe
Opis fizyczny
  • Department of Pathology and Veterinary Diagnostic, Warsaw University of Life Sciences-SGGW, Nowoursynowska 159c, 02-766 Warsaw, Poland
  • Veterinary Surgery Białobrzeska in Warsaw, Warsaw, Poland
  • Veterinary Surgery Białobrzeska in Warsaw, Warsaw, Poland
  • Laboratory of Veterinary Epidemiology and Economics, Faculty of Veterinary Medicine, Warsaw University of Life Sciences-SGGW, Nowoursynowska 159c, 02-766 Warsaw, Poland
  • Department of Pathology and Veterinary Diagnostic, Warsaw University of Life Sciences-SGGW, Nowoursynowska 159c, 02-766 Warsaw, Poland
  • Altman DG, Machin D, Bryant TN, Gardner MJ (2000) Statistics with confidence, 1st ed., London: BMJ Books. pp 46-48.
  • Carminato A, Vascellari M, Marchioro W, Melchiotti E, Mutinelli F (2011) Microchip-associated fibrosarcoma in a cat. Vet Dermatol 22: 565-569.
  • Couto SS, Griffey SM, Duarte PC, Madewell BR (2002) Feline vaccine-associated fibrosarcoma: morphologic distinctions. Vet Pathol 39: 33-41.
  • Daly MK, Saba CF, Crochik SS, Howerth EW, Kosarek CE, Cornell KK, Roberts RE, Northrup NC (2008) Fibrosar-coma adjacent to the site of microchip implantation in a cat. J Feline Med Surg 10: 202-205.
  • Vaccination Guidelines Group, Day MJ, Horzinek MC, Schultz R.D (2010) WSAVA guidelines for the vaccination of dogs and cats. J Small Anim Pract 51: 1-32.
  • Dean RS, Pfeiffer DU, Adams VJ (2013) The incidence of feline injection site sarcomas in the United Kingdom. BMC Vet Res 9: 17.
  • Esplin DG, Bigelow M, McGill LD, Wilson SR (1999) Fibrosarcoma at the site of lufenuron injection in a cat. Vet Canc Soc Newslet 23: 8-9.
  • Gobar GM, Kass PH (2002) World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in cats. J Am Vet Med Assoc 220: 1477-1482.
  • Giudice C, Stefanello D, Sala M, Cantatore M, Russo F, Romussi S, Travetti O, Di Giancamillo M, Grieco V (2010) Feline injection-site sarcoma: recurrence, tumour grading and surgical margin status evaluated using the three- dimensional histological technique. Vet J 186: 84-88.
  • Hendrick MJ, Brooks JJ (1994) Postvaccinal sarcomas in the cat: histology and immunohistochemistry. Vet Pathol 31: 126-129.
  • Hendrick MJ, Goldschmidt MH (1991) Do injection site reactions induce fibrosarcoma in cats J Am Vet Med Assoc 199: 968.
  • Hendrick MJ, Goldschmidt MH, Shofer FS, Wang YY, Somlyo AP (1992) Postvaccinal sarcomas in the cat: epidemiology and electron probe microanalytical identification of aluminium. Cancer Res 52: 5391-5394.
  • Hendrick MJ, Shofer FS, Goldshmidt MH, Haviland JC, Schelling SH, Engler SJ, Gliatto JM (1994) Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992). J Am Vet Med Assoc 205: 1425-1429.
  • Kass PH, Spangler WL, Hendrick MJ, McGill LD, Esplin DG, Lester S, Slater M, Meyer EK, Boucher F, Peters EM, Gobar GG, Htoo T, Decile K (2003) Multicenter case-control study of risk factors associated with development of vaccine-associated sarcomas in cats. J Am Vet Med Assoc 223: 1283-1292.
  • Kirpensteijn J (2006) Feline injection site-associated sarcoma: Is it a reason to critically evaluate our vaccination policies? Vet Microbiol 117: 59-65.
  • Kuntz CA, Dernell WS, Powers BE, Devitt C, Straw RC, Withrow SJ (1997) Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). J Am Vet Med Assoc 211: 1147-1151.
  • McEntee MC, Page RL (2001) Feline vaccine-associated sarcomas. J Vet Intern Med 15: 176-182.
  • Martano M, Morello E, Buraco P (2011) Feline injection-site sarcoma: past, present and future perspectives. Vet J 188: 136-141.
  • Martano M, Morello E, Iussich S, Buracco P (2012) A case of feline injection-site sarcoma at the site of cisplatin injections. J Feline Med Surg 14: 751-754.
  • Munday JS, Banyay K, Aberdein D, French AF (2011) Development of an injection site sarcoma shortly after meloxicam injection in an unvaccinated cat. J Feline Med Surg 13: 988-991.
  • Powers BE, Hoopes PJ, Ehrhart EJ (1995) Tumour diagnosis, grading, and staging. Semin Vet Med Surg (Small Anim) 10: 158-167.
  • Romanelli G, Marconato L, Olivero D, Massari F, Zini E (2008) Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007). J Am Vet Med Assoc 232: 1193-1199.
  • Shaw SC, Kent MS, Gordon IK, Collins CJ, Greasby TA, Beckett LA, Hammond GM, Skorupski KA (2009) Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990-2006). J Am Vet Med Assoc 234: 376-380.
  • Wilcock B, Wilcock A, Bottoms K (2012) Feline postvac-cinal sarcoma: 20 years later. Can Vet J 53: 430-434.
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.